Logo

Celera Licenses Databases to Europe s Largest Biotech Firm

Dec 20, 2001

NEW YORK, Dec. 20 - Celera Genomics has licensed its genomic databases to Serono, Europe's largest biotech firm, Celera said on Thursday.

 

Financial terms of the multi-year subscription agreement were not disclosed.

 

"This agreement is another important element in our expanding genomics program," said Silvano Fumero, senior executive vice president for research and pharmaceutical development at Serono. He added that the Applera unit's mouse and human genome sequences "will support Serono's scientific efforts to discover novel targets and therapeutic proteins."

 

Serono, considered the third-largest biotech in the world in revenue, is based in Geneva.

Breaking News
The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.